YAMAMOTO Yoshiyuki
- Articles
- Systemic chemotherapy combined with anti-epidermal growth factor receptor antibody therapy for RAS wild-type appendiceal signet-ring cell carcinoma: a series of three cases
Hirose Suguru; Enami Chiaki; Kawamatsu Natsumi; Ito Y...
INTERNATIONAL CANCER CONFERENCE JOURNAL/Epub, 2021-08 - Usefulness of argon plasma coagulation for bleeding around hepaticojejunal anastomosis
Tange Yoshitaka; Hasegawa Naoyuki; Sugiyama Yutaro; En...
DEN Open, 2021-11 - Enhanced G1 arrest and apoptosis via MDM4/MDM2 double knockdown and MEK inhibition in wild-type TP53 colon and gastric cancer cells with aberrant KRAS signaling
Wang Xiaoxuan; Yamamoto Yoshiyuki; Imanishi Mamiko; Zh...
ONCOLOGY LETTERS/22(1), 2021-07 - MDM4 as a Prognostic Factor for Patients With Gastric Cancer With Low Expression of p53
Zhang Xiaochen; Yamamoto Yoshiyuki; Wang Xiaoxuan; Sat...
ANTICANCER RESEARCH/41(3)/pp.1475-1483, 2021-03 - Retrospective analysis of neoadjuvant chemotherapy followed by surgery versus definitive chemoradiotherapy with proton beam for locally advanced esophageal squamous cell carcinoma
Ogawa Koichi; Ishikawa Hitoshi; Hisakura Katsuji; Hiro...
International journal of clinical oncology/26(10)/pp.1856-1863, 2021-07 - Optimal Maintenance Strategy for First-Line Oxaliplatin-Containing Therapy with or without Bevacizumab in Patients with Metastatic Colorectal Cancer: A Meta-Analysis
Moriwaki Toshikazu; Gosho Masahiko; Sugaya Akinori; Ya...
Cancer research and treatment/53(3)/pp.703-713, 2020-12 - A Durable Response after the Discontinuation of Nivolumab in an Advanced Gastric Cancer Patient
Yatsuda Yukino; Ikeda Takafumi; Yamada Takeshi; Yamamo...
Internal Medicine/60(7)/pp.1011-1017, 2021 - Retrospective analysis for the efficacy and safety of nivolumab in advanced gastric cancer patients according to ascites burden
Suzuki Hirosumi; Yamada Takeshi; Sugaya Akinori; Ueyam...
International journal of clinical oncology/26/pp.370-377, 2020-10 - Clinical utility of circulating tumor DNA sequencing in advanced gastrointestinal cancer: SCRUM-Japan GI-SCREEN and GOZILA studies
Nakamura Yoshiaki; Taniguchi Hiroya; Ikeda Masafumi; B...
NATURE MEDICINE/26(12)/pp.1859-1864, 2020-10 - Malignant Pleural Mesothelioma in Patients Who Previously Received Radiotherapy for their First Malignant Tumor
Sekine Ikuo; Yamamoto Yoshiyuki; Suzuki Toshio; Suzuki...
Internal Medicine/60(5)/pp.663-665, 2020-10 - Dramatic Recovery From Cardiovascular Collapse: Paclitaxel as an Urgent Treatment for Primary Cardiac Angiosarcoma
Suzuki Toshio; Yamamoto Yoshiyuki; Sakamoto Noriaki; S...
Internal Medicine/60(1)/pp.67-71, 2020-08 - Mediastinal Neuroendocrine Carcinoma Slowly Growing for 8 Years after Surgical Resection of Esophageal Squamous Cell Carcinoma.
Hirose Suguru; Hasegawa Naoyuki; Kawai Hitomi; Yamaura...
Internal medicine (Tokyo, Japan)/59(20)/pp.2505-2509, 2020-07 - A case of advanced gastric cancer showing HER2 positivity after chemotherapy
Hirose Suguru; Moriwaki Toshikazu; Yamaura Masamichi; ...
INTERNATIONAL CANCER CONFERENCE JOURNAL/9(3)/pp.112-115, 2020-04 - Phase II study of S-1 on alternate days plus bevacizumab in patients aged ≥ 75 years with metastatic colorectal cancer (J-SAVER)
Moriwaki Toshikazu; Sakai Yoshinori; Ishida Hiroyasu; ...
International journal of clinical oncology/24(10)/pp.1214-1222, 2019-05 - Efficacy of adjuvant chemotherapy after resection of pulmonary metastasis from colorectal cancer: a propensity score-matched analysis
Imanishi Mamiko; Yamamoto Yoshiyuki; Hamano Yukako; Ya...
European journal of cancer (Oxford, England : 1990)/106/pp.69-77, 2018-11 - Augmented antitumor activity of 5-FU by double knockdown of MDM4 and MDM2 in colon and gastric cancer cells
Imanishi Mamiko; Yamamoto Yoshiyuki; Wang Xiaoxuan; Su...
Cancer science/110(2)/pp.639-649, 2018-11 - Anal canal adenocarcinoma with neuroendocrine features accompanying secondary extramammary Paget disease, successfully treated with modified FOLFOX6: a case report.
Yamaura Masamichi; Yamada Takeshi; Watanabe Rei; Kawai...
BMC cancer/18(1)/p.1142, 2018-11 - Effectiveness of an endoscopic biopsy procedure using EUS-FNA and EMR-C for diagnosing adenocarcinoma arising from ectopic pancreas: two case reports and a literature review.
Endo Shinji; Saito Rie; Ochi Daisuke; Yamada Takeshi; ...
Intern Med./53(10)/pp.1055-1062, 2014-10 - Successful Long-term Management with a Single Administration of Tri-weekly Nab-paclitaxel in a Patient with Advanced Gastric Cancer with Peritoneal Dissemination
Matano Daisuke; Moriwaki Toshikazu; Tange Yoshitaka; N...
Internal Medicine/56(8)/pp.921-923, 2017-04 - Utility of epirubicin-incorporating micelles tagged with anti-tissue factor antibody clone with no anticoagulant effect
Sugaya Akinori; Hyodo Ichinosuke; Koga Yoshikatsu; Yam...
Cancer science/107(3)/pp.335-340, 2016-03 - Correlations of survival with progression-free survival, response rate, and disease control rate in advanced biliary tract cancer: A meta-analysis of randomised trials of first-line chemotherapy
Moriwaki Toshikazu; Yamamoto Yoshiyuki; Gosho Masahiko...
British Journal of Cancer/114(8)/pp.881-888, 2016-03 - Is serum HER2 ECD a predictive biomarker for response to trastuzumab in advanced gastric cancer?
Yamada Takeshi; Yamamoto Yoshiyuki; Moriwaki Toshikazu...
Journal of Gastroenterology/51(5)/pp.506-507, 2016-02 - Feasibility study of the Fab fragment of a monoclonal antibody against tissue factor as a diagnostic tool
Tsumura Ryo; Sato Ryuta; Furuya Fumiaki; Koga Yoshika...
INTERNATIONAL JOURNAL OF ONCOLOGY/47(6)/pp.2107-2114, 2015-12 - Enhanced antitumor effect of anti-tissue factor antibody-conjugated epirubicin-incorporating micelles in xenograft models
Yamamoto Yoshiyuki; Hyodo Ichinosuke; Koga Yoshikatsu; ...
CANCER SCIENCE/106(5)/pp.627-634, 2015-05 - Effect of combined treatment with the epirubicin-incorporating micelles (NC-6300) and 1,2-diaminocyclohexane platinum (II)-incorporating micelles (NC-4016) on a human gastric cancer model.
Yamamoto Yoshiyuki; Hyodo Ichinosuke; Takigahira Misat...
INTERNATIONAL JOURNAL OF CANCER/135(1)/pp.214-223, 2014-07 - more...
- Systemic chemotherapy combined with anti-epidermal growth factor receptor antibody therapy for RAS wild-type appendiceal signet-ring cell carcinoma: a series of three cases